New findings in cardio-oncology from CARDIOCARE
CARDIOCARE, a European project dedicated to the prevention and monitoring of cardiotoxicity in older women with breast cancer, has concluded with a positive final assessment. Among the consortium partners is IMS – Istituto di Management Sanitario, one of the founding organizations of Bio4Dreams and still part of its network.
Launched in 2021 and funded under the European Union’s Horizon 2020 programme, CARDIOCARE brought together 12 organizations from seven European countries, coordinated by the University of Ioannina in Greece.
The project passed its final review by experts appointed by the European Commission. According to the summary provided by IMS, the reviewers acknowledged the excellence of the results achieved.
An integrated approach to cardio-oncology
CARDIOCARE was conceived to address the needs of a population still underrepresented in clinical research: older women with breast cancer, who are particularly exposed to cardiovascular complications during cancer treatment.
The project developed a multidisciplinary approach, combining conventional cardiac monitoring with clinical, psychological and molecular data, as well as information collected through wearable devices.
The proposed approach was tested in a prospective multicenter clinical study involving 640 patients, with a 12-month follow-up period.
Among the most significant findings was the identification of a vulnerability index associated with the subsequent development of cardiotoxicity, which could help identify patients at higher risk earlier and support more personalized clinical management strategies.
Although the behavioral and psychological intervention did not produce a statistically significant reduction in the primary endpoint of cardiotoxicity, favorable trends were observed in several cardiac parameters.
The project also demonstrated the feasibility of integrating digital health solutions for cardio-oncology across different healthcare settings, developing an interoperable infrastructure and a valuable body of data for future research.
The contribution of IMS
Within CARDIOCARE, IMS coordinated the working groups dedicated to ethical and regulatory aspects, while also managing the methodological aspects of the multicenter clinical study and contributing to research activities.
The results achieved through CARDIOCARE are the outcome of multidisciplinary work that demonstrates the value of the expertise and collaborations within the Bio4Dreams network.
For further information: visit the official CARDIOCARE website.

